Achievements and challenges in composite tissue allotransplantation

Transplant International

Volumn 24, Issue 8, 2011, Pages 760-769

  Schneeberger, Stefan ^a,b   Landin, Luis ^c   Jableki, Jerzy ^d   Butler, Peter ^e   Hoehnke, Christoph ^f   Brandacher, Gerald ^a,b   Morelon, Emmanuel ^g  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Subdepartment of Replantation of Limbs   (Poland)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITÉ DE LYON   (France)

Author keywords

composite tissue transplantation; face transplantation; hand transplantation; indications; outcome; rejection

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; ALLOTRANSPLANTATION; ARM AMPUTATION; CLOSTRIDIUM DIFFICILE INFECTION; COMPOSITE GRAFT; COMPOSITE TISSUE ALLOTRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DONOR; EPSTEIN BARR VIRUS INFECTION; FACE MALFORMATION; FACIAL TRANSPLANTATION; FOREARM; GRAFT RECIPIENT; GRAFT REJECTION; HAND AMPUTATION; HERPES VIRUS INFECTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; KIDNEY FAILURE; LAW; LEUKOPENIA; MYCOSIS; NECROSIS; NERVE REGENERATION; OSTEITIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; THROMBOSIS; TISSUE TRANSPLANTATION;

ARM; EUROPE; FACIAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; HAND; HUMANS; IMMUNOSUPPRESSION; MALE; THROMBOSIS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79960138137     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01261.x     Document Type: Review

References (86)

1. Gilbert R,. Transplant is successful with a cadaver forearm. Med Trib Med News 1964; 5: 20.
2. Dubernard JM, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H,. Human hand allograft: report on first six months. Lancet 1999; 353: 1315.
3. Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW Jr, Starzl TE,. Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet 1983; 157: 309.
4. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D,. Cadaveric renal transplantation under cyclosporine-steroid therapy. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
5. Jones JW, Ustuner ET, Zdicavosky M, et al. Long-term survival of an extremity composite tissue allograft with FK-506-mycophenolate mofetil therapy. Surgery 1999; 126: 384.
6. Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005; 79: 1210.
7. Graham B, Adkins P, Tsai TM, Firrell J, Breidenbach WC,. Major replantation versus revision amputation and prosthetic fitting in the upper extremity: a late functional outcomes study. J Hand Surg Am 1998; 23: 783.
8. Petruzzo P, Lanzetta M, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2010; 90: 1590.
9. Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: experience with 3 patients. Surgery 2008; 144: 638, discussion 43.
10. Brandacher G, Ninkovic M, Piza-Katzer H, et al. The Innsbruck hand transplant program: update at 8 years after the first transplant. Transplant Proc 2009; 41: 491.
11. Landin L, Cavadas PC, Nthumba P, Ibanez J, Vera-Sempere F,. Preliminary results of bilateral arm transplantation. Transplantation 2009; 88: 749.
12. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003; 361: 2173.
13. Cipriani R, Contedini F, Santoli M, et al. Abdominal wall transplantation with microsurgical technique. Am J Transplant 2007; 7: 1304.
14. Selvaggi G, Levi DM, Cipriani R, Sgarzani R, Pinna AD, Tzakis AG,. Abdominal wall transplantation: surgical and immunologic aspects. Transplant Proc 2009; 41: 521.
15. Birgfeld CB, Low DW,. Total face reconstruction using a pre-expanded, bilateral, extended, parascapular free flap. Ann Plast Surg 2006; 56: 565.
16. Hofer SO, Mureau MA,. Improving outcomes in aesthetic facial reconstruction. Clin Plast Surg 2009; 36: 345.
17. Wolfaardt J, Sugar A, Wilkes G,. Advanced technology and the future of facial prosthetics in head and neck reconstruction. Int J Oral Maxillofac Surg 2003; 32: 121.
18. Paletta CE, Pokorny JJ, Rumbolo PM,. Skin grafts. In:, Mathes S, ed. Plastic Surgery, 2nd edn. Philadelphia: Elsevier, 2006: 293-316.
19. Baumeister S, Follmar KE, Erdmann D, Baccarani A, Levin LS,. Tissue expansion of free and pedicled flaps after transfer: possibilities and indications. J Reconstr Microsurg 2007; 23: 63.
20. Jeng SF, Kuo YR, Wei FC, Su CY, Chien CY,. Reconstruction of concomitant lip and cheek through-and-through defects with combined free flap and an advancement flap from the remaining lip. Plast Reconstr Surg 2004; 113: 491.
21. Jeng SF, Kuo YR, Wei FC, Su CY, Chien CY,. Total lower lip reconstruction with a composite radial forearm-palmaris longus tendon flap: a clinical series. Plast Reconstr Surg 2004; 113: 19.
22. Ngo K, Goldstein D, Neligan P, Gilbert R,. Colorimetric evaluation of facial skin and free flap donor sites in various ethnic populations. J Otolaryngol 2006; 35: 249.
23. Neligan PC,. Principles of reconstruction. In:, Neligan PC, Wei F-C, eds. Microsurgical Reconstruction of the Head and Neck. St. Louis: Quality Medical Publishing, 2010: 129-34.
24. Meningaud JP, Paraskevas A, Ingallina F, Bouhana E, Lantieri L,. Face transplant graft procurement: a preclinical and clinical study. Plast Reconstr Surg 2008; 122: 1383.
25. Paradis C, Siemionow M, Papay F, et al. Ethical considerations in the first American face transplant. Plast Reconstr Surg 2010; 126: 896.
26. Ebrahimzadeh MH, Fattahi AS, Nejad AB,. Long-term follow-up of Iranian veteran upper extremity amputees from the Iran-Iraq war (1980-1988). J Trauma 2006; 61: 886.
27. Schuind F, Abramowicz D, Schneeberger S,. Hand transplantation: the state-of-the-art. J Hand Surg Eur Vol 2007; 32: 2.
28. Cavadas PC, Landin L, Ibañez J,. Bilateral hand transplantation: result at 20 months. J Hand Surg Eur Vol 2009; 34: 434.
29. Landin L, Cavadas PC, Garcia-Cosmes P, Thione A, Vera-Sempere F,. Perioperative ischemic injury and fibrotic degeneration of muscle in a forearm allograft: functional follow-up at 32 months post transplantation. Ann Plast Surg 2011; 66: 202.
30. Jablecki J, Kaczmarzyk L, Domanasiewicz A, Chelmonski A, Boratynska M, Patrzalek D,. Hand transplantation-Polish program. Transplant Proc 2010; 42: 3321.
31. Gazarian A, Abrahamyan DO, Petruzzo P, et al. Hand allografts: experience from Lyon team. Ann Chir Plast Esthet 2007; 52: 424.
32. Schneeberger S, Ninkovic M, Piza-Katzer H, et al. Status 5 years after bilateral hand transplantation. Am J Transplant 2006; 6: 834.
33. Breidenbach WC, Ravindra K, Blair B, et al. Transplant arteriopathy in clinical hand transplantation. Abstract Book of the 9th Meeting of the International Society of Hand and Composite Tissue Allotransplantation; 2009 Sep 11-12; Valencia, Spain.
34. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003; 76: 688.
35. Landin L, Cavadas PC, Ibañez J, Roger I,. Malignant skin tumor in a composite tissue (bilateral hand) allograft recipient. Plast Reconstr Surg 2010; 125: 20e.
36. Margreiter R, Brandacher G, Ninkovic M, Steurer W, Kreczy A, Schneeberger S,. A double-hand transplant can be worth the effort. Transplantation 2002; 74: 85.
37. Jablecki J, Kaczmarzyk L, Patrzalek D, et al. A detailed comparison of the functional outcome after midforearm replantations versus midforearm transplantation. Transplant Proc 2009; 41: 513.
38. Schneeberger S, Ninkovic M, Gabl M, et al. First forearm transplantation: outcome at 3 years. Am J Transplant 2007; 7: 1753.
39. Schneeberger S, Kreczy A, Brandacher G, Steurer W, Margreiter R,. Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H. Am J Transplant 2004; 4: 1372.
40. Datta D, Selvarajah K, Davey N,. Functional outcome of patients with proximal upper limb deficiency-acquired and congenital. Clin Rehabil 2004; 18: 172.
41. Landin L, Cavadas PC, Rodriguez-Perez JC, et al. Improvement in renal function after late conversion to sirolimus-based immunosuppression in composite tissue allotransplantation. Transplantation 2010; 90: 691.
42. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: early report. Lancet 2006; 368: 203.
43. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007; 357: 2451.
44. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: a 2-year follow-up study. Lancet 2008; 372: 631.
45. Siemionow M, Papay F, Alam D, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009; 374: 203.
46. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 2008; 372: 639.
47. Meningaud JP, Benjoar MD, Hivelin M, Hermeziu O, Toure G, Lantieri L,. The procurement of total human face graft for allotransplantation: a preclinical study and the first clinical case. Plast Reconstr Surg 2010; 126: 1181.
48. Hui-Chou HG, Nam AJ, Rodriguez ED,. Clinical facial composite tissue allotransplantation: a review of the first four global experiences and future implications. Plast Reconstr Surg 2010; 125: 538, Review.
49. Coffman KL, Gordon C, Siemionow M,. Psychological outcomes with face transplantation: overview and case report. Curr Opin Organ Transplant 2010; 15: 236.
50. Gordon CR, Siemionow M, Papay F, et al. The world's experience with facial transplantation: what have we learned thus far? Ann Plast Surg 2009; 63: 572, Review.
51. Kanitakis J, Badet L, Petruzzo P, et al. Clinicopathologic monitoring of the skin and oral mucosa of the first human face allograft: report on the first eight months. Transplantation 2006; 82: 1610.
52. Kanitakis J,. The challenge of dermatopathological diagnosis of composite tissue allograft rejection: a review. J Cutan Pathol 2008; 35: 738, Review.
53. Hequet O, Morelon E, Bourgeot JP, et al. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor. Bone Marrow Transplant 2008; 41: 1059.
54. Karl A, Birbaumer N, Lutzenberger W, Cohen LG, Flor H,. Rorganization of motor and somatosensory cortex in upper extremity amputees with phantom limb pain. J Neurosci 2001; 21: 3609.
55. Giraux P, Sirigu A, Schneider F, Dubernard JM,. Cortical reorganization in motor cortex after graft of both hands. Nat Neurosci 2001; 4: 691.
56. Vargas C, Aballéa A, Rodrigues E, et al. Re-emergence of hand-muscle representations in human motor cortex after hand allograft. PNAS 2009; 106: 7197.
57. Murray JE,. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg 1971; 47: 425.
58. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ,. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401.
59. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003; 75: 25.
60. Ravindra KV, Wu S, Bozulic L, Xu H, Breidenbach WC, Ildstad ST,. Composite tissue transplantation: a rapidly advancing field. Transplant Proc 2008; 40: 1237.
61. Siemionow M, Nasir S,. Impact of donor bone marrow on survival of composite tissue allografts. Ann Plast Surg 2008; 60: 455.
62. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502.
63. Tzakis AG, Kato T, Nishida S, et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003; 75: 1512.
64. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
65. Ciancio G, Miller J, Garcia-Morales RO, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001; 71: 827.
66. Starzl TE,. Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med 2008; 358: 407.
67. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
68. Wekerle T, Sykes M,. Mixed chimerism and transplantation tolerance. Annu Rev Med 2001; 52: 353.
69. Pilat N, Wekerle T,. Transplantation tolerance through mixed chimerism. Nat Rev Nephrol 2010; 6: 594.
70. Orlando G, Hematti P, Stratta RJ, et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 2010; 252: 915.
71. Fehr T, Sykes M,. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008; 21: 1118.
72. Sykes M,. Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials. Transplantation 2009; 87: 309.
73. Klimczak A, Unal S, Jankowska A, Coburn C, Siemionow M,. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model. Bone Marrow Transplant 2007; 40: 373.
74. Sykes M,. Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417.
75. Ramsamooj R, Llull R, Black KS, Hewitt CW,. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 1999; 104: 1365.
76. Li XC, Turka LA,. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010; 6: 577.
77. Pilat N, Wekerle T,. Mechanistic and therapeutic role of regulatory T cells in tolerance through mixed chimerism. Curr Opin Organ Transplant 2010; 15: 725.
78. Matta BM, Castellaneta A, Thomson AW,. Tolerogenic plasmacytoid DC. Eur J Immunol 2010; 40: 2667.
79. Morelli AE, Thomson AW,. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610.
80. Silk KM, Fairchild PJ,. Harnessing dendritic cells for the induction of transplantation tolerance. Curr Opin Organ Transplant 2009; 14: 344.
81. Cahill T, Hettiaratchy S, Clarke A, Butler PE,. Predictive value and limitations of animal models for human transplantation: do we need more models for facial transplantation? Transpl Rev 2006; 20: 76.
82. European Parliament. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004. Available at:. Accessed April 21, 2011. http://eurlex.europa.eu/LexUriServ/site/en/oj/2004/l-102/l- 10220040407en00480058.pdf
83. Knobloch K, Vogt PM, Rennekampff HO,. Composite tissue allotransplantation (CTA): organ or tissue transplantation? Handchir Mikrochir Plast Chir 2009; 41: 205.
84. Meeting of Competent Authorities on Tissues and Cells. October 2009. Agenda item 10, section 10.5. Available at: http://ec.europa.eu/health/archive/ ph-threats/human-substance/documents/ev-20091019-mi-en.pdf. Accessed April 21, 2011.
85. Clarke A, Malloy J, White P, et al. A model for structuring the donor discussion in emergent transplant procedures. Prog Transplant 2008; 18: 157.
86. Clarke A, Murphy F, White P, Brough V, Renshaw A, Butler PE,. Transplant professionals' attitudes toward facial transplantation in the United Kingdom. Prog Transplant 2007; 17: 228.